Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous magnesium sulfate as complementary therapy for acute exacerbation of COPD
IRCT20150315021480N8Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Number of breaths. Started Oct 2017; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20150315021480N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150315021480N8.